<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transforming growth factor-β (TGFβ) signaling drives <z:hpo ids='HP_0002617'>aneurysm</z:hpo> progression in <z:e sem="disease" ids="C0679225" disease_type="Disease or Syndrome" abbrv="">multiple disorders</z:e>, including <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>), and therapies that inhibit this signaling cascade are in clinical trials </plain></SENT>
<SENT sid="1" pm="."><plain>TGFβ can stimulate multiple intracellular signaling pathways, but it is unclear which of these pathways drives <z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">aortic disease</z:e> and, when inhibited, which result in disease amelioration </plain></SENT>
<SENT sid="2" pm="."><plain>Here we show that extracellular signal-regulated kinase (ERK) 1 and 2 and Smad2 are activated in a mouse model of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>, and both are inhibited by therapies directed against TGFβ </plain></SENT>
<SENT sid="3" pm="."><plain>Whereas selective inhibition of ERK1/2 activation ameliorated aortic growth, Smad4 deficiency exacerbated <z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">aortic disease</z:e> and caused premature <z:hpo ids='HP_0011420'>death</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> mice </plain></SENT>
<SENT sid="4" pm="."><plain>Smad4-deficient <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> mice uniquely showed activation of Jun N-terminal kinase-1 (JNK1), and a JNK <z:chebi fb="68" ids="48706">antagonist</z:chebi> ameliorated aortic growth in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> mice that lacked or retained full Smad4 expression </plain></SENT>
<SENT sid="5" pm="."><plain>Thus, noncanonical (Smad-independent) TGFβ signaling is a prominent driver of <z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">aortic disease</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> mice, and inhibition of the ERK1/2 or JNK1 pathways is a potential therapeutic strategy for the disease </plain></SENT>
</text></document>